CNC
GSK icon

Citizens & Northern Corp’s GSK GSK Stock Holding History

Citizens & Northern Corp’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05M Sell
39,176
-860
-2% -$45.5K 0.47% 42
2026
Q1 		$2.21M Buy
40,036
+441
+1% +$23.9K 0.55% 32
2025
Q4 		$1.94M Sell
39,595
-1,935
-5% -$90.2K 0.48% 41
2025
Q3 		$1.79M Buy
41,530
+94
+0.2% +$3.67K 0.44% 44
2025
Q2 		$1.59M Buy
41,436
+1,447
+4% +$55.3K 0.43% 51
2025
Q1 		$1.55M Sell
39,989
-1,154
-3% -$42.2K 0.44% 51
2024
Q4 		$1.39M Buy
41,143
+1,207
+3% +$43.5K 0.38% 55
2024
Q3 		$1.63M Buy
39,936
+3,151
+9% +$129K 0.49% 47
2024
Q2 		$1.42M Sell
36,785
-1,758
-5% -$74K 0.44% 53
2024
Q1 		$1.65M Sell
38,543
-1,042
-3% -$43K 0.56% 42
2023
Q4 		$1.47M Sell
39,585
-1,426
-3% -$51.2K 0.52% 47
2023
Q3 		$1.49M Sell
41,011
-1,430
-3% -$50.8K 0.6% 43
2023
Q2 		$1.51M Buy
42,441
+1,786
+4% +$64.1K 0.57% 45
2023
Q1 		$1.45M Buy
40,655
+388
+1% +$13.6K 0.56% 48
2022
Q4 		$1.41M Buy
+40,267
New +$1.34M 0.58% 49

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return

Citizens & Northern Corp's GSK Position: Q2 2026 in Review

Citizens & Northern Corp reduced its GSK (GSK) stake by 2.1% in Q2 2026, selling an estimated $45.5K and leaving 39,176 shares worth $2.05M. The position accounts for 0.47% of the portfolio, ranked #42.

Citizens & Northern Corp first reported a position in GSK in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.21M in Q1 2026. 186 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Citizens & Northern Corp held 39,176 shares of GSK worth $2.05M as of Q2 2026.
  • Citizens & Northern Corp sold 860 GSK shares in Q2 2026, an estimated $45.5K.
  • GSK made up 0.47% of Citizens & Northern Corp's portfolio in Q2 2026, its #42 holding.
  • Citizens & Northern Corp first reported a position in GSK in Q4 2022 and has held it in 15 quarters since.
  • Citizens & Northern Corp's GSK position peaked at $2.21M in Q1 2026.
  • 186 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Citizens & Northern Corp's 13F filing for Q2 2026, filed 17 Jul 2026.